Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Solid Phase Peptide Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115819493A reveals a novel acid-base washing method improving crude peptide purity by approximately 30%, offering cost-effective manufacturing for GLP-1 analogs.
Patent CN110964097B details a high-yield solid-phase fragment method for Exenatide, achieving over 99.7% purity and significantly reducing manufacturing costs.
Advanced all-solid-phase synthesis of Thymalfasin using amino resin and DMB-modified dipeptides. Delivers high purity and yield for reliable pharmaceutical intermediates supply.
Patent CN110894227A details a novel two-fragment solid-phase synthesis for Liraglutide, offering higher purity and reduced oily intermediates for reliable pharmaceutical manufacturing.
Patent CN113444150B reveals a novel solid-phase method for Plecanatide, offering superior yield and purity. Discover cost-effective manufacturing solutions for this GI drug.
Patent CN111378009A reveals a novel solid-phase synthesis for octreotide using aldehyde resin. This method simplifies processing, reduces side reactions, and offers cost-effective manufacturing solutions.
Patent CN118085036B enables aqueous cyclization reducing solvent waste. Offers supply chain reliability and cost reduction in peptide manufacturing for global partners.
Novel patent CN114044813B details high-yield procatide preparation offering supply chain stability and significant cost reduction in API manufacturing for global partners.
Advanced secondary cyclization method for Plecanatide synthesis ensures high yield and purity. Reliable supply chain partner for scalable pharmaceutical intermediate production.
Patent CN103554229B introduces a novel solid phase synthesis method for buserelin offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Advanced solid-phase fragment synthesis for GpTx-1 and Analogue 71. High purity, scalable process for Nav1.7 pain therapeutics. Cost-effective manufacturing solution.
Advanced solid-phase peptide synthesis method reduces costs and improves supply chain reliability for high-purity Exenatide manufacturing globally.
Advanced solid-phase synthesis of antibacterial cyclic hexapeptide Thermoactinoamide A. Patent CN108440654B offers high yield, scalable production for reliable pharmaceutical suppliers.
Patent CN1222537C reveals a novel Fmoc-strategy for Eptifibatide synthesis, eliminating toxic HF and reducing cycle time. Ideal for reliable peptide intermediate sourcing.
Patent CN114478708B reveals an 8+2 solid-phase method for high-purity ganirelix, offering significant cost reduction and scalable manufacturing for global supply chains.
Patent CN1712399B details a novel hybrid synthesis of paclitaxel-MDP conjugates improving solubility and efficacy. Discover cost-effective manufacturing strategies for advanced API intermediates.